Base collateral: the implication
USDC is a documented overlap. Other networks or token funding routes are outside this shared-deployment lens.
DN Decision Briefs / Evidence comparison
gTrade vs Veranta (formerly Avantis)
Compare the documented conditions, not an unsupported winner. Base is the shared deployment in this comparison; fee evidence is incomplete and no comparable live execution tests have been performed.
What Matters
Compare like with like. Keep the gaps visible.
Two dated documentation snapshots. This is a comparison of evidence coverage and product conditions, not a ranking, current quote or recommendation.
The shared network is Base and the documented collateral overlap is USDC. There is no blended score or cheapest-platform claim. Documentation coverage differs; that does not establish a difference in safety.
DN Evidence Block
The conditions side by side.
| Decision factor | gTrade | Veranta (formerly Avantis) |
|---|---|---|
| Base collateral | USDC and BtcUSD are listed for Base. Gains: Trade Collaterals | USDC margin is described for the Base protocol. Veranta product explanation, 1 October 2026Veranta Terms of Service, revised September 2026 |
| Cost structure | The reviewed fee guide covers opening/closing fees, spread, price impact and funding/borrowing. Gains: Fees & Spread | The overview separates RWA commission treatment from profit-sharing Upside Perps; detailed rates remain unverified here. Veranta documentation overview |
| Execution evidence | No live execution test in the DN snapshot. | Provider RFQ/AMM descriptions are not an independent DN performance measurement. Veranta product explanation, 1 October 2026 |
| Permissions | No live permission audit in this brief. | One-click execution is advertised; delegated authority and revocation were not verified. Veranta documentation overview |
| Eligibility evidence | Individual eligibility was not assessed in this snapshot. | Reviewed terms include U.S.-person and restricted-person exclusions; other conditions apply. Veranta Terms of Service, revised September 2026 |
Cost structure: the implication
No cheapest-venue conclusion. Compare the same asset, mode, size, direction, time and holding period before measuring costs.
Execution evidence: the implication
Neither platform receives a fill-quality, latency or stop-loss score.
Permissions: the implication
Do not infer comparable security from wallet-based access or gas sponsorship.
Eligibility evidence: the implication
Evidence coverage is asymmetric. An unknown is not permission to use a platform.
Evidence boundary
No invented rates. No implied guarantees.
- Comparable live quotes and total holding costs
- Comparable execution and withdrawal observations
- Individual eligibility and safe permission settings
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
Keep the evidence.
Keep its limits.
The receipt preserves all underlying evidence snapshots and the comparison at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
- Scope
- Base (shared deployment)
- Collateral scope
- USDC
- Evidence version
- 1.0.0 / 2026-10-14
- Live tested
- No
Change record
Reviewed dates, not inferred launch dates.
DN publication
Initial comparison pinned to gTrade 1.0.0 and Veranta 1.0.0. Provider claims and DN measurement gaps remain separate.
Review triggers: Either underlying brief receives a new version; Changed documentation or substantiated correction; The earliest underlying review deadline. No automated provider surveillance runs for this brief.
How to use this research
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN has referral relationships or entries for these platforms. This comparison has no partner CTAs, payout-based ordering or overall winner.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.